Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05671133 · ClinicalTrials.gov registry record · NA

Effectiveness and Implementation of a Clinician Decision Support System to Prevent Suicidal Behaviors

A NA study of Suicide and Suicide, Attempted, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
4,000
Enrollment target
1
Study location

NCT05671133: Recruiting NA study of Suicide and Suicide, Attempted, sponsored by Massachusetts General Hospital.

NCT05671133 is a NA study of Suicide and Suicide, Attempted that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 4,000 participants, below the 6,946-participant average among 92 other Suicide trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05671133, a NA study of Suicide and Suicide, Attempted, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
4,000 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this project are to evaluate a comprehensive, practice-ready, and deployment-focused strategy for improving the prediction and prevention of suicide attempts among a sample of 4,000 patients presenting to an ED with a psychiatric concern. Our first aim is to evaluate the effects of providing information about risk of patient suicidal behavior to ED clinicians. We hypothesize that patients randomly assigned to have their clinician receive their risk score will have a lower rate of suicide attempts during 6-month follow-up and that this effect will be mediated by changes in clinician decision-making.

Primary Outcome

The primary endpoint is the occurrence (0,1) of a suicide attempt during the 6 months following randomization. The outcome will be measured as a single binary variable, indicating whether a participant experienced at least one suicide attempt during the follow-up period. This outcome will be ascertained using participant self-report and EHR documentation. Self-reported suicide attempts will be assessed using questions from the Self-Injurious Thoughts and Behaviors Interview (SITBI), a widely use

Interventions

  • DIAGNOSTIC_TEST Clinician Decision Support Tool

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 4,000 participants
Start Date 2025-02-25
Est. Completion 2028-06
Phase NA
Massachusetts General Hospital

2,032 total trials

What NCT05671133 shows while recruiting

NCT05671133 is an interventional study that assigns participants to a tested intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, below the 6,946-participant average among 92 other Suicide trials with a reported enrollment target (42% lower).

The record links to 2 conditions, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which Clinician Decision Support Tool is the first listed.

NCT05671133 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05671133 about?

NCT05671133 is a clinical study titled "Effectiveness and Implementation of a Clinician Decision Support System to Prevent Suicidal Behaviors". The primary aim of this project are to evaluate a comprehensive, practice-ready, and deployment-focused strategy for improving the prediction and prevention of suicide attempts among a sample of 4,000 patients presenting to an ED with a psychiatric concern. Our first aim is to evaluate the effects o...

What is the current status of trial NCT05671133?

This trial is currently recruiting. It is a NA study. The enrollment target is 4,000 participants. The study started on 2025-02-25. Estimated completion is 2028-06.

What conditions does trial NCT05671133 study?

This clinical trial studies the following conditions: Suicide, Suicide, Attempted.

What interventions are being tested in trial NCT05671133?

The interventions under investigation include: Clinician Decision Support Tool (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05671133?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05671133 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05671133's enrollment target sits among peer trials

4,000 5th of 92 higher than 87 of 92 other Suicide trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00227253 · 4,000 participants

    Chromosome 18 Clinical Research Center

  • NCT00811148 · 4,000 participants

    Florida Center for Brain Tumor Research

  • NCT00897117 · 4,000 participants

    Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer

  • NCT00899301 · 4,000 participants

    Collecting and Storing Tissue Samples From Women With or Without Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05671133, the US trial registry maintained by the National Library of Medicine. NCT05671133 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.